Aron M. Knickerbocker

2019

In 2019, Aron M. Knickerbocker earned a total compensation of $7.5M as Former President and Chief Executive Officer at Five Prime Therapeutics, a 262% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$173,813
Option Awards$1,269,866
Salary$388,402
Stock Awards$1,294,262
Other$4,422,162
Total$7,548,505

Knickerbocker received $4.4M in other compensation, accounting for 59% of the total pay in 2019.

Knickerbocker also received $173.8K in non-equity incentive plan, $1.3M in option awards, $388.4K in salary and $1.3M in stock awards.

Rankings

In 2019, Aron M. Knickerbocker's compensation ranked 1,212th out of 13,971 executives tracked by ExecPay. In other words, Knickerbocker earned more than 91.3% of executives.

ClassificationRankingPercentile
All
1,212
out of 13,971
91st
Division
Manufacturing
420
out of 5,701
93rd
Major group
Chemicals And Allied Products
125
out of 2,200
94th
Industry group
Drugs
100
out of 1,886
95th
Industry
Pharmaceutical Preparations
75
out of 1,398
95th
Source: SEC filing on April 3, 2020.

Knickerbocker's colleagues

We found three more compensation records of executives who worked with Aron M. Knickerbocker at Five Prime Therapeutics in 2019.

2019

Helen Collins

Five Prime Therapeutics

Chief Medical Officer

2019

Francis Sarena

Five Prime Therapeutics

Secretary

2019

William Ringo

Five Prime Therapeutics

Chief Executive Officer

News

You may also like